Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Acosta

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|May 1, 1997
Pharmacokinetics and safety of concentration-controlled oral zidovudine therapyE P Acosta, K Henry, L M Page, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcomaJ D Moore, B J Dezube, P Gill, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Concentration-controlled zidovudine therapyC V Fletcher, E P Acosta, K Henry, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavirT N Kakuda, L M Page, P L Anderson, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 22, 2025
Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplantJ S Guimbellot, Ashritha Chalamalla, Elizabeth Baker, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|May 1, 1997
Pharmacokinetics and safety of concentration-controlled oral zidovudine therapyE P Acosta, K Henry, L M Page, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
Phase I dose escalation pharmacokinetics of O-(chloroacetylcarbamoyl) fumagillol (TNP-470) and its metabolites in AIDS patients with Kaposi's sarcomaJ D Moore, B J Dezube, P Gill, et al.
AIDS (London, England)|January 12, 2001
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patientsX J Zhou, D V Havlir, D D Richman, et al.
HIV Clinical Trials|December 14, 2001
Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant womenE P Acosta, C Zorrilla, R Van Dyke, et al.
Clinical Pharmacology and Therapeutics|October 3, 1998
Concentration-controlled zidovudine therapyC V Fletcher, E P Acosta, K Henry, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavirT N Kakuda, L M Page, P L Anderson, et al.
AIDS (London, England)|January 11, 2000
Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884C V Fletcher, E P Acosta, H Cheng, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 22, 2025
Elexacaftor-tezacaftor-ivacaftor pharmacokinetics with concurrent tacrolimus administration after lung transplantJ S Guimbellot, Ashritha Chalamalla, Elizabeth Baker, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
AIDS (London, England)|September 13, 2000
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370D R Kuritzkes, R L Bassett, V A Johnson, et al.
Pageof 4